Wellington Management Group LLP Decreases Stock Position in Chemed Co. (NYSE:CHE)

Wellington Management Group LLP decreased its position in Chemed Co. (NYSE:CHE) by 95.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,242 shares of the company’s stock after selling 65,275 shares during the quarter. Wellington Management Group LLP’s holdings in Chemed were worth $1,948,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the company. HighTower Advisors LLC increased its stake in Chemed by 78.0% during the 3rd quarter. HighTower Advisors LLC now owns 3,730 shares of the company’s stock worth $2,246,000 after buying an additional 1,634 shares during the period. Hsbc Holdings PLC grew its stake in shares of Chemed by 110.0% during the second quarter. Hsbc Holdings PLC now owns 10,638 shares of the company’s stock valued at $5,801,000 after acquiring an additional 5,572 shares in the last quarter. Evergreen Capital Management LLC purchased a new stake in shares of Chemed during the second quarter worth about $7,812,000. Quest Partners LLC lifted its stake in shares of Chemed by 634.3% in the second quarter. Quest Partners LLC now owns 1,990 shares of the company’s stock worth $1,080,000 after acquiring an additional 1,719 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its holdings in Chemed by 1.5% in the second quarter. Envestnet Asset Management Inc. now owns 74,461 shares of the company’s stock valued at $40,401,000 after purchasing an additional 1,106 shares during the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Chemed Trading Down 1.2 %

Shares of CHE opened at $518.59 on Thursday. Chemed Co. has a 52 week low of $516.91 and a 52 week high of $654.62. The firm has a market cap of $7.80 billion, a price-to-earnings ratio of 26.20, a PEG ratio of 2.32 and a beta of 0.46. The stock has a 50 day moving average of $568.69 and a 200-day moving average of $564.69.

Chemed (NYSE:CHE) last released its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The business had revenue of $606.18 million during the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.32 EPS. On average, sell-side analysts predict that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a yield of 0.39%. Chemed’s dividend payout ratio is currently 10.11%.

Wall Street Analyst Weigh In

CHE has been the topic of a number of recent analyst reports. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th. Royal Bank of Canada reduced their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $572.77, for a total value of $1,145,540.00. Following the sale, the chief executive officer now owns 101,735 shares of the company’s stock, valued at $58,270,755.95. This trade represents a 1.93 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director George J. Walsh III sold 400 shares of the business’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the transaction, the director now directly owns 3,046 shares of the company’s stock, valued at $1,819,893.62. The trade was a 11.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,132 shares of company stock worth $3,003,502 over the last ninety days. Company insiders own 3.32% of the company’s stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.